ITRM Projected Dividend Yield
Iterum Therapeutics plc ( NASDAQ : ITRM )Iterum Therapeutics is a clinical-stage pharmaceutical company focused on developing and commercializing sulopenem oral to be an oral penem available in the U.S. and an oral and intravenous (IV) branded penem available globally. The objective of Co.'s sulopenem program is to deliver to patients an oral and IV formulation of sulopenem approved in the U.S. and Europe for the treatment of infections due to resistant gram-negative pathogens. Co. has also developed sulopenem in an oral tablet formulation, sulopenem etzadroxil-probenecid. 20 YEAR PERFORMANCE RESULTS |
ITRM Dividend History Detail ITRM Dividend News ITRM Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |